Our material focus areas
- Access to medicines
- Patient safety and product quality
- Patient advocacy
Why this matters
Health is a human right and foundational to a sustainable society. Enabling healthcare professionals to source the medicines they need for their patients is the reason we exist. Our experience, expertise and infrastructure mean that we can support them to treat their patients even when a medicine is unlicensed in their home country. We believe that access to medicines should be global by design, and everything we do is focused on making that vision of the future a reality.
Our approach
We ensure that medicines are available where and when they are needed by leveraging our expertise in
pharmaceutical supply chains and the international regulatory environment. We find pathways to supplying
medicines to practitioners and patients, no matter the obstacles we encounter.
Key targets and plans
We will actively define the targets for this pillar in early 2024. One of the key metrics we plan to track is our Client Net Promoter Score (NPS), beginning with a baseline measurement from which we can set an ambitious target that supports our patient-centric approach. We are working to champion the voices of our patients, raising understanding amongst investors about the value of engaging patients in clinical development for health science companies. Meeting their needs is our priority, so amplifying their voices is an essential.
We will maintain a 100% compliance rate in all audits and Competent Authority Inspections. During the next 12 months, we will continue to centralise and standardise our quality activities to align with global regulatory frameworks, protecting our ability to effectively distribute medicines worldwide.
Through our ongoing strategic partnership with 7Bridges, we will achieve global logistics excellence, optimising deliveries to patients and building greater operational resilience with their AI-powered logistics technology. This partnership is critical in ensuring we accelerate access to medicines for those who need it most.
Alongside this, the opening of our new flagship Dublin facility will expand our presence in Europe, serving as
a hub of innovation and driving force in accelerating access to medicines.
Alignment with the UN SDGs
Our sustainability commitments are aligned to:
- SDG 3
Good health and well-being - SDG 16
Peace, justice and strong institutions
Specifically we support SDG targets:
- 3.8: Achieve universal health coverage, including financial risk protection, access to quality essential
health-care services and access to safe, effective, quality and affordable essential medicines and
vaccines for all - 16.6: Develop effective, accountable and transparent institutions at all levels
- 16.5: Substantially reduce corruption and bribery in all their forms
- 16.7: Ensure responsive, inclusive, participatory and representative decision-making at all levels
